To determine the effect of the compounds on differentiation, expression of several erythroid (CD71/CD235) and megakaryocytic (CD41/CD61) differentiation markers was determined in murine erythroleukemia CB7 and human HEL cell lines after drug treatment. The gene discussed is TFRC; the disease is erythroleukemia.